NCT01345357 2013-01-18Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell LymphomaTeva Branded Pharmaceutical Products R&D, Inc.Phase 1 Completed24 enrolled